Categories: News

Sensor Receives Conditional Approval

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

Toronto, Ontario–(Newsfile Corp. – November 30, 2023) – Sensor Technologies Corp. (CSE: SENS) (the “Company” or “Sensor”) is pleased to announce that, further to its press releases of June 30, 2023, the Company has received conditional approval from the Canadian Securities Exchange (“CSE”) with respect to the Company’s proposed change of business from a technology issuer to an investment issuer.

Final approval for the proposed change of business is conditional on the Company fulfilling the following conditions, among others:

  • the successful completion of the private placement for aggregate proceeds $500,000;

  • the completion of proposed debt conversions;

  • the completion of the Company’s investment in each of Robotic StemCell BioTech Ltd., Blockchain Assets Management Group Limited and 14125339 Canada Inc. (as described in the Company’s press release of January 19, 2023); and

  • the completion of any and all outstanding CSE application documentation and payment of applicable fees.

The Company intends to fulfill all of the conditions as soon as possible.

Corporation contact:

Philip Wong, Chief Executive Officer
email: ssphilipwong@gmail.com

The CSE has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.

NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/189196

Staff

Recent Posts

Aktiia secures $42 million in Series B funding round and rebrands to Hilo

With fresh funding round, the health tech pioneer continues to work toward managing the world's…

2 hours ago

RaySearch releases RayStation v2025

STOCKHOLM, May 2, 2025 /PRNewswire/ -- RaySearch Laboratories AB (publ) announces the launch of RayStation®*…

2 hours ago

Cosmo Announces EU MDR Certification for Endovision’s Cerebro, expanding its real-time AI ecosystem

Dublin, Ireland--(Newsfile Corp. - May 2, 2025) - Cosmo is excited to announce that Endovision…

6 hours ago

America’s Poison Centers: Using Trusted Sources for Your Critical Health Information

Poison Help (1-800-222-1222/ PoisonHelp.org) provides 24/7 free, expert advice from one of 53 nationally accredited,…

14 hours ago

Olympus Demonstrates New AI Endoscopy Solution at DDW®

The OLYSENSE Platform Aims to Strengthen Clinical Decision-Making by Leveraging Cloud-based Connectivity and AI Computing…

14 hours ago